These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 14308777)

  • 1. [COMPARATIVE EVOLUTION OF HEMAGGLUTINATION-INHIBITING, COMPLEMENT-FIXING AND NEUTRALIZING ANTIBODIES DURING AN EPIDEMIC DUE TO ADENOVIRUS 7A].
    HENRY M; SOHIER R; CHARDONNET Y
    Ann Inst Pasteur (Paris); 1965 Feb; 108():180-95. PubMed ID: 14308777
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutralizing, hemagglutination-inhibiting and group complement-fixing antibody responses in human adenovirus infections.
    Schmidt NJ; Lennette EH; King CJ
    J Immunol; 1966 Jul; 97(1):64-74. PubMed ID: 4288350
    [No Abstract]   [Full Text] [Related]  

  • 3. [ON THE PRESENCE OF COMPLEMENT-BINDING AND NEUTRALIZING ANTIBODIES AGAINST DIFFERENT ADENOVIRUSES].
    DOEHNER L
    Z Immunitats Allergieforsch; 1965 Mar; 128():251-60. PubMed ID: 14307153
    [No Abstract]   [Full Text] [Related]  

  • 4. [COMPARATIVE STUDY OF ADENOVIRAL ANTIBODIES WITH THE PASSIVE HEMAGGLUTINATION TEST AND COMPLEMENT FIXATION TEST].
    MAGUREANU E; GROBNICU M; MUSATESCU M; RADU I; VORNICESCU M
    Microbiol Parazitol Epidemiol (Bucur); 1964; 9():351-8. PubMed ID: 14250950
    [No Abstract]   [Full Text] [Related]  

  • 5. Studies on the serologic identification of adenovirus. I. Comparison of the hemagglutination, conglutinating complement adsorption, and complement fixation tests.
    PRIER JE; LEBEAU RW
    J Lab Clin Med; 1958 Mar; 51(3):495-500. PubMed ID: 13514265
    [No Abstract]   [Full Text] [Related]  

  • 6. PRODUCTION AND STANDARDIZATION OF ADENOVIRUS TYPES 1 TO 18 REFERENCE ANTISERA.
    RAFAJKO RR
    Am J Hyg; 1964 May; 79():310-9. PubMed ID: 14159950
    [No Abstract]   [Full Text] [Related]  

  • 7. STUDIES ON THE AETIOLOGY OF EPIDEMIC KERATOCONJUNCTIVITIS OBSERVED IN BUDAPEST DURING WINTER, 1961--1962.
    NASZ I; KULCSAR G; DAN P; LENGYEL A; CSERBA I
    Acta Microbiol Acad Sci Hung; 1963; 10():35-40. PubMed ID: 14043494
    [No Abstract]   [Full Text] [Related]  

  • 8. RELATIONSHIP OF THE ADENOVIRUS ERYTHROCYTE-RECEPTOR-MODIFYING FACTOR TO THE TYPE-SPECIFIC COMPLEMENT-FIXING ANTIGEN.
    KASEL JA; HUBER M
    Proc Soc Exp Biol Med; 1964 May; 116():16-8. PubMed ID: 14200096
    [No Abstract]   [Full Text] [Related]  

  • 9. [IMPORTANCE OF THE HEMAGGLUTINATION INHIBITION REACTION IN THE DIAGNOSIS OF EPIDEMIC KERATOCONJUNCTIVITIS].
    NAS I; KULCSAR G; DAN P; LENGYEL A; CSORBA I
    Vopr Virusol; 1964; 26():112-3. PubMed ID: 14155932
    [No Abstract]   [Full Text] [Related]  

  • 10. USE OF DRIED WHOLE BLOOD COLLECTED ON FILTER PAPER DISKS IN ADENOVIRUS COMPLEMENT FIXATION AND MEASLES HEMAGGLUTINATION INHIBITION TESTS.
    BRODY JA; MCALISTER R; HASLEY R; LEE P
    J Immunol; 1964 Jun; 92():854-7. PubMed ID: 14210790
    [No Abstract]   [Full Text] [Related]  

  • 11. POLYOMA AND OTHER INDIGENOUS MOUSE VIRUSES.
    ROWE WP; HARTLEY JW; HUEBNER RJ
    Lab Anim Care; 1963 Apr; 13():SUPPL166-75. PubMed ID: 14043135
    [No Abstract]   [Full Text] [Related]  

  • 12. [ADENOVIRUS ANTIBODIES. SEROLOGICAL STUDY OF THEIR INCIDENCE IN VARIOUS POPULATION GROUPS].
    MAGUREANU E; GROBNICO M; MUSETESCO M
    Presse Med (1893); 1964 Dec; 72():3113-5. PubMed ID: 14221351
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemagglutination-inhibiting, complement-fixing and neutralizing antibody responses in ECHO 6 infection, including studies on heterotypic responses.
    BUSSELL RH; KARZON DT; BARRON AL; HALL FT
    J Immunol; 1962 Jan; 88():47-54. PubMed ID: 13875157
    [No Abstract]   [Full Text] [Related]  

  • 14. The sensitivity of the complement fixation test for the detection of adenovirus infections in infants and children with lower respiratory disease.
    Portnoy B; Salvatore MA; Hanes B; Hammer DI; Leedom JM; Jambazian A; Eckert HL
    Am J Epidemiol; 1967 Sep; 86(2):362-71. PubMed ID: 4293745
    [No Abstract]   [Full Text] [Related]  

  • 15. [Laboratory procedures in adenoviruses. IV. The influence of antiglobulin and complement on neutralization and hemagglutination-inhibition (author's transl)].
    Zimmer E; Wigand R
    Zentralbl Bakteriol Orig A; 1977 Jun; 238(2):177-83. PubMed ID: 196455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PRODUCTION OF SPECIFIC NEUTRALIZING ANTIBODY WITH SOLUBLE ANTIGENS OF TYPE 5 ADENOVIRUS.
    WILCOX WC; GINSBERG HS
    Proc Soc Exp Biol Med; 1963 Oct; 114():37-42. PubMed ID: 14076907
    [No Abstract]   [Full Text] [Related]  

  • 17. HUMAN ADENOVIRUS TYPE 31. A NEW SEROTYPE WITH ONCOGENIC PROPERTIES.
    PEREIRA MS; PERIERA HG; CLARKE SK
    Lancet; 1965 Jan; 1(7375):21-3. PubMed ID: 14246675
    [No Abstract]   [Full Text] [Related]  

  • 18. Isolation of an adenovirus from the brain of a pig.
    Kasza L
    Am J Vet Res; 1966 May; 27(118):751-8. PubMed ID: 4289789
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of the hemagglutination-inhibition, neutralization and complement fixation tests in the assay of antibody to measles.
    CUTCHINS EC
    J Immunol; 1962 Jun; 88():788-95. PubMed ID: 13882798
    [No Abstract]   [Full Text] [Related]  

  • 20. ADENOVIRUS HAEMAGGLUTINATION-INHIBITING ANTIBODIES IN HUMAN SERA.
    LENGYEL A; NASZ I
    Acta Microbiol Acad Sci Hung; 1964; 11():105-13. PubMed ID: 14230648
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.